These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36099977)

  • 1. Personalized approach using wearable technology for early detection of atrial fibrillation in high-risk primary care patients (PATCH-AF): Study protocol for a cluster randomized controlled trial.
    Brik T; Lucassen WAM; Harskamp RE; Karregat EPM; Himmelreich JCL; Busschers WB; Moll van Charante EP
    Am Heart J; 2022 Dec; 254():172-182. PubMed ID: 36099977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation: The mSToPS Randomized Clinical Trial.
    Steinhubl SR; Waalen J; Edwards AM; Ariniello LM; Mehta RR; Ebner GS; Carter C; Baca-Motes K; Felicione E; Sarich T; Topol EJ
    JAMA; 2018 Jul; 320(2):146-155. PubMed ID: 29998336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detecting and Diagnosing Atrial Fibrillation (D2AF): study protocol for a cluster randomised controlled trial.
    Uittenbogaart SB; Verbiest-van Gurp N; Erkens PM; Lucassen WA; Knottnerus JA; Winkens B; van Weert HC; Stoffers HE
    Trials; 2015 Oct; 16():478. PubMed ID: 26499449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of Atrial Fibrillation in a Large Population Using Wearable Devices: The Fitbit Heart Study.
    Lubitz SA; Faranesh AZ; Selvaggi C; Atlas SJ; McManus DD; Singer DE; Pagoto S; McConnell MV; Pantelopoulos A; Foulkes AS
    Circulation; 2022 Nov; 146(19):1415-1424. PubMed ID: 36148649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lead-I ECG for detecting atrial fibrillation in patients with an irregular pulse using single time point testing: a systematic review and economic evaluation.
    Duarte R; Stainthorpe A; Greenhalgh J; Richardson M; Nevitt S; Mahon J; Kotas E; Boland A; Thom H; Marshall T; Hall M; Takwoingi Y
    Health Technol Assess; 2020 Jan; 24(3):1-164. PubMed ID: 31933471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening for undiagnosed atrial fibrillation using a single-lead electrocardiogram at primary care visits: patient uptake and practitioner perspectives from the VITAL-AF trial.
    Atlas SJ; Ashburner JM; Chang Y; Borowsky LH; Ellinor PT; McManus DD; Lubitz SA; Singer DE
    BMC Prim Care; 2023 Jun; 24(1):135. PubMed ID: 37391738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for paroxysmal atrial fibrillation in primary care using Holter monitoring and intermittent, ambulatory single-lead electrocardiography.
    Karregat EPM; Gurp NV; Bouwman AC; Uittenbogaart SB; Himmelreich JCL; Lucassen WAM; Krul SPJ; van Kesteren HAM; Luermans JGLM; van Weert HCPM; Stoffers HEJH
    Int J Cardiol; 2021 Dec; 345():41-46. PubMed ID: 34687805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Opportunistic screening versus usual care for detection of atrial fibrillation in primary care: cluster randomised controlled trial.
    Uittenbogaart SB; Verbiest-van Gurp N; Lucassen WAM; Winkens B; Nielen M; Erkens PMG; Knottnerus JA; van Weert HCPM; Stoffers HEJH
    BMJ; 2020 Sep; 370():m3208. PubMed ID: 32938633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-Led Mass Screening for Atrial Fibrillation in the Older Population Using Handheld Electrocardiographic Devices Integrated With a Clinician-Coordinated Remote Central Monitoring System: Protocol for a Randomized Controlled Trial and Process Evaluation.
    Wong KC; Nguyen TN; Marschner S; Turnbull S; Burns MJ; Ne JYA; Gopal V; Indrawansa AB; Trankle SA; Usherwood T; Kumar S; Lindley RI; Chow CK
    JMIR Res Protoc; 2022 Feb; 11(2):e34778. PubMed ID: 35103614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Continuous Electrocardiogram Monitoring on Detection of Undiagnosed Atrial Fibrillation After Hospitalization for Cardiac Surgery: A Randomized Clinical Trial.
    Ha ACT; Verma S; Mazer CD; Quan A; Yanagawa B; Latter DA; Yau TM; Jacques F; Brown CD; Singal RK; Yamashita MH; Saha T; Teoh KH; Lam BK; Deyell MW; Wilson M; Hibino M; Cheung CC; Kosmopoulos A; Garg V; Brodutch S; Teoh H; Zuo F; Thorpe KE; Jüni P; Bhatt DL; Verma A;
    JAMA Netw Open; 2021 Aug; 4(8):e2121867. PubMed ID: 34448866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cluster randomised controlled trial of screening for atrial fibrillation in people aged 70 years and over to reduce stroke: protocol for the pilot study for the SAFER trial.
    Williams K; Modi RN; Dymond A; Hoare S; Powell A; Burt J; Edwards D; Lund J; Johnson R; Lobban T; Lown M; Sweeting MJ; Thom H; Kaptoge S; Fusco F; Morris S; Lip G; Armstrong N; Cowie MR; Fitzmaurice DA; Freedman B; Griffin SJ; Sutton S; Hobbs FR; McManus RJ; Mant J; Safer Authorship Group T
    BMJ Open; 2022 Sep; 12(9):e065066. PubMed ID: 36691194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ReducinG stroke by screening for UndiAgnosed atRial fibrillation in elderly inDividuals (GUARD-AF): Rationale and design of the GUARD-AF randomized trial of screening for atrial fibrillation with a 14-day patch-based continuous ECG monitor.
    Singer DE; Atlas SJ; Go AS; Lopes RD; Lubitz SA; McManus DD; Revkin JH; Mills D; Crosson LA; Lenane JC; Aronson RS
    Am Heart J; 2022 Jul; 249():76-85. PubMed ID: 35472303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening for Atrial Fibrillation in the Older Population: A Randomized Clinical Trial.
    Gladstone DJ; Wachter R; Schmalstieg-Bahr K; Quinn FR; Hummers E; Ivers N; Marsden T; Thornton A; Djuric A; Suerbaum J; von Grünhagen D; McIntyre WF; Benz AP; Wong JA; Merali F; Henein S; Nichol C; Connolly SJ; Healey JS;
    JAMA Cardiol; 2021 May; 6(5):558-567. PubMed ID: 33625468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Handheld ECG Tracking of in-hOspital Atrial Fibrillation The HECTO-AF trial Clinical Study Protocol.
    Schukraft S; Mancinetti M; Hayoz D; Faucherre Y; Cook S; Arroyo D; Puricel S
    Trials; 2019 Jan; 20(1):92. PubMed ID: 30700332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NICE atrial fibrillation guideline snubs wearable technology: a missed opportunity?
    Briosa e Gala A; Pope MT; Leo M; Lobban T; Betts TR
    Clin Med (Lond); 2022 Jan; 22(1):77-82. PubMed ID: 35078798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opportunistic screening versus usual care for diagnosing atrial fibrillation in general practice: a cluster randomised controlled trial.
    Kaasenbrood F; Hollander M; de Bruijn SH; Dolmans CP; Tieleman RG; Hoes AW; Rutten FH
    Br J Gen Pract; 2020 Jun; 70(695):e427-e433. PubMed ID: 31988084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of undiagnosed atrial fibrillation patients using a machine learning risk prediction algorithm and diagnostic testing (PULsE-AI): Study protocol for a randomised controlled trial.
    Hill NR; Arden C; Beresford-Hulme L; Camm AJ; Clifton D; Davies DW; Farooqui U; Gordon J; Groves L; Hurst M; Lawton S; Lister S; Mallen C; Martin AC; McEwan P; Pollock KG; Rogers J; Sandler B; Sugrue DM; Cohen AT
    Contemp Clin Trials; 2020 Dec; 99():106191. PubMed ID: 33091585
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardiac monitors to detect atrial fibrillation after cryptogenic stroke: a systematic review and economic evaluation.
    Edwards SJ; Wakefield V; Jhita T; Kew K; Cain P; Marceniuk G
    Health Technol Assess; 2020 Jan; 24(5):1-184. PubMed ID: 31944175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Consumer-Led Screening for Atrial Fibrillation: Frontier Review of the AF-SCREEN International Collaboration.
    Brandes A; Stavrakis S; Freedman B; Antoniou S; Boriani G; Camm AJ; Chow CK; Ding E; Engdahl J; Gibson MM; Golovchiner G; Glotzer T; Guo Y; Healey JS; Hills MT; Johnson L; Lip GYH; Lobban T; Macfarlane PW; Marcus GM; McManus DD; Neubeck L; Orchard J; Perez MV; Schnabel RB; Smyth B; Steinhubl S; Turakhia MP
    Circulation; 2022 Nov; 146(19):1461-1474. PubMed ID: 36343103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.